相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The year in cardiology: heart failure The year in cardiology 2019
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2020)
Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure
Susan Stienen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure
Joao Pedro Ferreira et al.
HEART (2019)
Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction A Secondary Analysis of TOPCAT Trial
Miranda Merrill et al.
JACC-HEART FAILURE (2019)
Prevention or Procrastination for Heart Failure? Why We Need a Universal Definition of Heart Failure
John G. F. Cleland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
MRAs in Elderly HF Patients Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT
Joao Pedro Ferreira et al.
JACC-HEART FAILURE (2019)
Rising incidence of heart failure demands action
Faiez Zannad
LANCET (2018)
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
Nathalie Conrad et al.
LANCET (2018)
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Myocardial fibrosis: biomedical research from bench to bedside
Mariann Gyoengyoesi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart OMics in AGEing (HOMAGE) Study
Lotte Jacobs et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction
Johan Lofsjogard et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Meta-Analysis of the Usefulness of Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart Failure and in the General Population
Tasnim F. Imran et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Serial galectin-3 and future cardiovascular disease in the general population
A. Rogier van der Velde et al.
HEART (2016)
Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure
Begona Lopez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population
Zhen-Yu Zhang et al.
PLOS ONE (2016)
Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
Circulating Biomarkers of Myocardial Fibrosis The Need for a Reappraisal
Begona Lopez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams et al.
LANCET (2015)
Fibrosis - A Common Pathway to Organ Injury and Failure
Don C. Rockey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Laurent Calvier et al.
JACC-HEART FAILURE (2015)
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
Frank Edelmann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Aldosterone Induced Galectin-3 Secretion In Vitro and In Vivo: From Cells to Humans
Yen-Hung Lin et al.
PLOS ONE (2014)
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database
Lotte Jacobs et al.
JOURNAL OF BIOMEDICAL RESEARCH (2014)
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Laurent Calvier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial
Frank Edelmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Age-Specific Normal Values for the Incremental Shuttle Walk Test in a Healthy British Population
Samantha Louise Harrison et al.
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION (2013)
A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome
Wojciech Kosmala et al.
JACC-CARDIOVASCULAR IMAGING (2011)
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results
Alessandro Boccanelli et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies
TA McDonagh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Increased collagen type I synthesis in patients with heart failure of hypertensive origin -: Relation to myocardial fibrosis
R Querejeta et al.
CIRCULATION (2004)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
分享论文
